Skip to main content

Building a Future-Proof IP Strategy for AI in Medtech

The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging analysis, drug discovery, clinical trial management, and countless other medical applications. This competitive landscape is driving substantial investment and rapid innovation, with established medtech providers, disruptive startups, and well-funded tech giants all striving to integrate AI into the medical industry and patient experience. 

LINKS 

Read “Building a Future-Proof IP Strategy for AI in Medtech,” co-authored by David J. Dykeman, Andrew (A.J.) Tibbetts, and Samuel S. Stone, published by Medical Product Outsourcing